Clinical Trial Update: Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atorvastatin for endothelial dysfunction and albuminuria in sickle cell disease; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Sickle Cell Nephropathy

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Sickle Cell Disease, Sickle Cell Nephropathy | Phase 2 | Status: COMPLETED | Results posted: 2019-02-05